Reuters logo
BRIEF-Xbrane Biopharma Q2 pre-tax loss widens to SEK 9.4 million
August 31, 2017 / 8:36 AM / 3 months ago

BRIEF-Xbrane Biopharma Q2 pre-tax loss widens to SEK 9.4 million

Aug 31 (Reuters) - XBRANE BIOPHARMA AB

* APRIL-JUNE NET SALES SEK 4.5 MILLION VERSUS SEK 1.0 MILLION YEAR AGO

* Q2 PRE-TAX LOSS SEK 9.4 MILLION VERSUS LOSS SEK 7.6 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below